# Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer

> **NCT00566540** · PHASE2 · TERMINATED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 11 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Paclitaxel
- **RADIATION:** Intensity-Modulated Radiation Therapy (IMRT) External Beam Radiation
- **PROCEDURE:** Triple endoscopy and biopsy

## Key facts

- **NCT ID:** NCT00566540
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12-11
- **Primary completion:** 2010-02-25
- **Final completion:** 2010-02-25
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Recruitment problems with study
- **Last updated:** 2021-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00566540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00566540, "Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00566540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*